The post Oracle to pay 2026’s second dividend in April; Here’s how 100 ORCL shares will earn appeared on BitcoinEthereumNews.com. Oracle (NYSE: ORCL) is set toThe post Oracle to pay 2026’s second dividend in April; Here’s how 100 ORCL shares will earn appeared on BitcoinEthereumNews.com. Oracle (NYSE: ORCL) is set to

Oracle to pay 2026’s second dividend in April; Here’s how 100 ORCL shares will earn

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Oracle (NYSE: ORCL) is set to pay its second dividend of 2026 on April 24, continuing its quarterly distribution schedule to reward shareholders.

The company has declared a quarterly dividend of $0.50 per share, unchanged from the previous payout. The last dividend, also $0.50, was paid on January 23.

For the upcoming payout, investors must be on record before the ex-dividend date of April 9, 2026. 

At a current share price of $140, Oracle offers a forward dividend yield of 1.42%, with total annual dividend payments amounting to $2 per share. 

Oracle stock dividend details. Source: Dividend.com

This reflects a relatively conservative payout ratio of 18.55%, suggesting the company retains a significant portion of earnings for reinvestment.

For investors, a holding of 100 ORCL shares will generate $50 from the April payout. On an annual basis, the same position would earn $200 in total dividends, assuming the current rate is maintained across all four quarterly payments.

The dividend comes at a time when ORCL stock has experienced notable volatility in recent sessions. 

Oracle stock fundamentals 

Shares have fallen more than 50% from their peak near $345 reached in September 2025, reflecting ongoing investor caution around the company’s heavy investment in artificial intelligence (AI) infrastructure.

This follows Oracle’s strong fiscal third-quarter 2026 results reported on March 10, which beat expectations. The company posted revenue of $17.2 billion, up 22% year over year, and adjusted earnings per share of $1.79.

Cloud revenue jumped 44% to $8.9 billion, while remaining performance obligations surged 325% to a record $553 billion, driven largely by major AI-related contracts. 

Management also raised fiscal 2027 revenue guidance and said no additional bond issuance is expected in calendar 2026 beyond prior plans.

Despite the solid results, the stock has faced renewed selling pressure amid multiple class-action lawsuits alleging the company misled investors about its AI data center capabilities, capital expenditure requirements, and the timeline for converting backlog into revenue. 

Legal risks remain in focus, with a key lead-plaintiff deadline set for April 6, 2026.

At the same time, some analysts have trimmed price targets amid partnership uncertainties, including reports that Microsoft may take over a Texas data center project initially linked to Oracle and OpenAI.

Broader concerns also center on Oracle’s aggressive $50 billion capital expenditure plan for fiscal 2026, which has pushed debt above $100 billion and led to periods of negative free cash flow, raising questions about balance sheet strain and the sustainability of its AI expansion.

The post Oracle to pay 2026’s second dividend in April; Here’s how 100 ORCL shares will earn appeared first on Finbold.

Source: https://finbold.com/oracle-to-pay-2026s-second-dividend-in-april-heres-how-100-orcl-shares-will-earn/

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.0631
$0.0631$0.0631
+0.81%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.